The comet assay is often applied in human biomonitoring. Most of the time the assay is performed with isolated peripheral blood mononuclear cells (PBMC). However, using whole blood instead of isolated cells reduces processing time, and only 20 µl is sufficient for analysis. In this study, a cryopreservation protocol for human whole blood for application in the comet assay was optimised by removing excess plasma before adding freezing medium. Cryopreservation of whole blood samples (n = 30) did not increase the detected level of strand breaks and formamidopyrimidine DNA glycosylase (FPG)-sensitive sites. Although there was no significant correlation with breaks measured in fresh whole blood, strand breaks detected in frozen whole blood were significantly correlated with breaks measured in frozen PBMC (Pearson correlation r = 0.54, P < 0.01). This correlation was however not observed for FPG-sensitive sites. Since we do not yet know the full extent to which cryopreservation might influence the blood cell population, care should be taken to ensure a similar cell type and storage conditions for all samples in one study.
Introduction
The single-cell gel electrophoresis, or comet assay, is a sensitive tool for measuring single-and double-strand DNA breaks. Since the first description of the assay by Ostling and Johanson in 1984 (1) , several new variants have been developed. Specific oxidative damage on DNA bases can be measured by means of lesion-specific endonucleases, such as bacterial formamidopyrimidine DNA glycosylase (FPG). This enzyme recognises 8-oxoguanine (8-oxoGua) and ring-opened purines, and removes these bases from the DNA backbone (2) . In this way, singlestrand breaks are created which can be detected with the comet assay.
The standard alkaline comet assay is mainly used for in vitro and in vivo genotoxicity testing, and has been extensively used in >300 environmental and occupational human biomonitoring studies (3, 4) . Most of the studies that investigate the effects of air pollution and seasonal variation mainly use isolated peripheral blood mononuclear cells (PBMC) (3, 4) . PBMC comprise a more homogenous cell population than the total leukocyte fraction, and PBMC have a longer lifetime compared with polymorphonuclear cells (5) . However, the use of whole blood has some important advantages, especially for longitudinal human biomonitoring studies. Often large sets of samples have to be processed at once. In these situations, whole blood takes considerably less processing time than samples requiring isolation of PBMC. Additionally, as little as 20-µl whole blood is sufficient for analysis (6, 7) , while generally larger samples are needed for isolation protocols. This is important in biomonitoring studies, where available volumes are often restricted due to ethical considerations. Another advantage of using whole blood is a reduced risk for generating damage by cell isolation procedures.
In this study, a cryopreservation protocol for human whole blood samples is described. Furthermore, DNA strand breaks and FPGsensitive sites in fresh and frozen whole blood and frozen isolated PBMC are compared.
Materials and Methods

Collection of whole blood and isolation of PBMC
Human peripheral blood was obtained from 48 healthy, non-smoking volunteers (aged 16-63 years, average 40 years, 53% men) on five different sampling days in the period of February and March 2010. Ethical approval for blood collection and analysis was granted by the ethical committee of the University of Antwerp (Reference No. UA A09 22) .
Whole blood was drawn into 10-ml heparin vacutainers and 8-ml Cell Preparation Tubes™ (BD) using a needle with a thickness of 21 Gauge. Both tubes were kept at room temperature until further analysis. Whole blood samples in heparin tubes were processed within 6 h after sampling. Cell Preparation Tubes™ for isolation of PBMC were centrifuged within 2 h after sampling, according to the manufacturer's protocol. In brief, Cell Preparation Tubes™ were centrifuged at 1500g for 25 min. Plasma and PBMC were transferred to 15-ml tubes and washed twice with ice-cold phosphate-buffered saline (PBS). Cell pellets were suspended in 800-µl ice-cold PBS. Samples were kept on ice between each step.
Cryopreservation protocol
Freezing medium consisted of 70% RPMI 1640 cell culture medium, 20% fetal calf serum (FCS) and 10% dimethyl sulfoxide (DMSO). Whole blood samples of 100 µl were shortly (±1 min) centrifuged at 1000g. Excess plasma was removed from the samples before adding 100-µl ice-cold freezing medium. For cryopreservation of PBMC, 300-µl freezing medium was added to a 300-µl aliquot of the 800-µl cells suspended in PBS. The remaining 500 µl were also stored in freezing medium for biobanking. All samples were frozen at −80°C using a 100% isopropyl alcohol freezing container (Mr. Frosty, Nalgene).
Preceding the comet assay, samples were quickly thawed in a 37°C water bath. A volume of 1-ml ice-cold PBS was added, and samples were centrifuged at 1000g for 15 min. Cell pellets were suspended in 20-80 µl ice-cold PBS.
Comet assay
Fresh whole blood treated with 2.5 mM ethyl methanesulfonate was used as a positive control for sample preparation and electrophoresis. For FPG treatment, a positive control was obtained by incubating 800-µl freshly isolated PBMC in PBS solution with 6 µl of photosensitiser Ro12-9786 (stock solution of 1.2 mM in DMSO). After waiting for 1 min, the cells were illuminated 2.5 min on ice, with light of an intensity of 10 000 lux. Ro12-9786 is a chemical that induces oxidative DNA damage upon illumination. After a washing step with 800-µl cold PBS, the cells were centrifuged and dissolved in 80-µl cold PBS. From this, slides were made in batch and kept in lysis buffer up to 6 months until use.
The comet assay was performed according to Singh et al. (8) with some modifications. For each individual, 20-µl fresh or frozen whole blood or 40-µl frozen PBMC suspension was added to 480-µl 0.8% low melting point agarose gel. Of this mixture, 100 µl was pipetted in quadruplicate on four Gelbond Films (Lonza) with the size of a conventional glass microscope slide. Gels were immersed in a cold lysis solution (2.25 M NaCl, 90 mM Na 2 EDTA, 9 mM Tris, 1% Triton X-100 and 10% DMSO) and kept at 4°C until further analysis. One Gelbond Film was used for analysis of regular strand breaks, while the three other Gelbond Films were used for determination of FPG-sensitive sites. In the latter case, the gels were washed twice (10 and 50 min) in cold enzyme buffer (100 mM NaCl, 40 mM HEPES, 0.5 mM Na 2 EDTA, 0.2 mg/ml BSA). FPG treatment consisted of immersing two slides in an enzyme solution [1/20.000 dilution of FPG stock solution (19.14 µg/ml) in enzyme buffer] during 1 h at 37°C. One slide was immersed in enzyme buffer for 1 h at 37°C as a buffer control.
Before electrophoresis slides were placed in the electrophoresis tank in an ice-cold alkaline solution (300 mM NaOH, 1 mM Na 2 EDTA) for 40 min to unwind the DNA. Electrophoresis was performed during 20 min at 4°C and 1 V/cm (0.7 V/cm across the elevated platform of the electrophoresis tank). Electrophoresis buffer was recirculated with a peristaltic pump from anode to cathode. After electrophoresis gels were washed once with PBS and twice with MilliQ water. Gels were stained with SYBR Gold, and image analysis was performed using a Zeiss fluorescence microscope equipped with a semi-automatic Metafer 3.5.3 system (Metasystems).
Three hundred Comets were automatically scored. The relative amount of DNA damage (% DNA in the tail compared with the total amount in the whole comet) was assessed by the system. Automatic analysis was followed by manual elimination of falsely scored comets. For whole blood samples, both polymorphonuclear and mononuclear cells were scored. Slides with <100 comets after manual correction were not used for statistical analysis. Results were displayed as median % tail DNA or lesions per bp [using a calibration curve (Supplementary Figure 1 , available at Mutagenesis Online) to transform the data as previously described (9)]. For FPG enzyme treatment, the average of the two slides' medians was taken. Both the comet assay and the image analysis were performed by a single person to minimise variations (2) .
Statistical analysis
Statistical analysis was performed using Statistica 8 software. Data were checked for normality using the Kolmogorov-Smirnov test. Effects of storage time on comet assay results were analysed using single linear regression. Pearson correlations and paired Student's t-tests were performed to analyse relations and differences between fresh whole blood, frozen whole blood and frozen isolated PBMC. Effects were considered significant if P < 0.05.
Results
Effect of bench time on DNA damage detected in fresh whole blood Whole blood samples from 48 healthy individuals were kept at room temperature and processed within 6 h after sampling on each of the 10 examination days. DNA migration ranged from 1.6 to 8.6% (0.08-0.44 lesions/10 6 bp) and from 4.7 to 38.7% (0.24-1.99 lesions/10 6 bp) tail DNA for strand breaks and FPG-sensitive sites, respectively. Percentage DNA in the comet tail is plotted in function of storage time in Figure 1 . There was no significant effect of storage time at room temperature.
Effects of cryopreservation on DNA damage levels detected in whole blood
Whole blood samples from 30 of the 48 individuals were stored in freezing medium at −80°C for a period of 12 months. Mean ± SD values for freshly processed and cryopreserved whole blood samples are listed in Table I . Figure 2 illustrates % DNA migration for fresh and frozen blood for each individual. No significant effects of cryopreservation were seen for strand breaks and FPG treatment (Figure 3) . However, the buffer control treated samples showed significantly higher DNA migration for frozen samples compared with freshly processed blood (P < 0.01, Figure 3 ) resulting in net FPG-sensitive sites to be lower in frozen compared with fresh samples (P < 0.05, Figure 3 ). Pearson correlation analysis did not show significant correlations between fresh and frozen whole blood samples for strand breaks and FPG-sensitive sites (Figure 4 ). Of note is that the levels of FPG-sensitive sites for the Ro12-9786-exposed assay controls were 33.13 ± 9.40% (1.60 ± 0.45 lesions/10 6 bp) on average in the assays with fresh whole blood samples and 63. 31 ± 10.31% (3.06 ± 0.50 lesions/10 6 bp) on average in the assays with frozen whole blood samples. Though, correcting the data for this assay control did not change the (lack off) statistically significant observations.
Comparison of DNA damage levels detected in frozen whole blood vs. frozen PBMC PBMC were isolated within 2 h after sampling using Cell Preparation Tubes™ and stored at −80°C in freezing medium for a period of 4-6 weeks. In general, detected damage tended to be lower in frozen isolated PBMC compared with whole blood samples (Table I) . Strand breaks were significantly lower in PBMC compared with that in frozen whole blood; nonetheless, a statistically significant positive correlation was observed (Pearson correlation r = 0.54, P < 0.01, Figure 4 ). The FPG buffer control, but not the FPG enzyme incubation, showed significantly lower values for the PBMC compared with the frozen whole blood, resulting in significantly lower net FPG-sensitive sites in frozen whole blood compared with PBMC (P < 0.05, Student's t-test). Though, when normalizing for the Ro12-9786-exposed assay controls, for which the average level of FPGsensitive sites was 39.06 ± 10.75% (2.02 ± 0.56 lesions/10 6 bp) in the assays with frozen PBMC, no statistically significant difference (P = 0.08) in the net FPG-sensitive sites was observed anymore. Regardless the normalisation for the Ro12-9786 assay controls, no significant correlation was observed for FPG-sensitive sites between frozen PBMC and whole blood (Figure 4 ).
Discussion
Effect of bench time on fresh whole blood samples Previous experiments in our lab showed a decrease in the viability of PBMC (Supplementary Table 1 , available at Mutagenesis Online), but no significant differences in strand breaks as well as FPG-sensitive sites (Supplementary Figure 2 and Table 2 , available at Mutagenesis Online) in whole blood samples stored at 4°C compared with room temperature were observed. The latter is in accordance with the findings of Anderson et al. (10) . To prevent loss of viability, blood samples were kept at room temperature after collection and were processed within 6 h, with no significant influence of bench time on the detected DNA damage. However, we saw a weak negative trend for DNA strand breaks with increasing storage time ( Figure 1A ; Supplementary Figure 2 , available at Mutagenesis Online). This was also described by Dusinska and Collins (2008) in PBMC samples processed within maximum 4 h after sampling (11) . Turbulence and shearing during blood drawing might induce mechanical damage which is restored in the time after collection. Anderson et al. previously showed that blood samples could be stored at room temperature for up to 4 days without increasing PBMC strand breaks (10). In our experience, whole blood can be kept for 72 h at room temperature without an increase in strand breaks (Supplementary  Table 3 , available at Mutagenesis Online).
FPG-sensitive sites seemed to be less stable. Figure 1B shows a weak increase of FPG-sensitive sites when samples are stored at room temperature. This effect was also observed by Dusinska and Collins (11) . In a previous experiment, whole blood samples kept at room temperature for 24 h showed a significant increase in FPG-sensitive sites (Supplementary Figure 3 , available at Mutagenesis Online). Therefore, the samples were processed within 6 h after sampling.
Effects of cryopreservation of whole blood
The use of frozen isolated PBMC for the comet assay is well established, and the detected damage is comparable with freshly processed isolated PBMC (12) (13) (14) . Here, we tested the cryopreservation of whole blood. Our results show that 100-µl whole blood samples stored in freezing medium at −80°C for a period of 12 months did not show more DNA strand breaks than freshly processed blood (Figure 3) . Net FPG-sensitive sites in frozen samples were lower than in freshly processed blood due to higher damage observed in the buffer controls. We cannot explain the higher amount of damage detected in the buffer controls of the frozen samples. No increase in DNA strand breaks was observed after freezing, and damage induced by the buffer solution is also included in the detected damage for the FPG treatment condition. Nevertheless, our cryopreservation protocol did not cause an increase in FPG-sensitive sites in whole blood samples stored at −80°C for up to 1 year. Previously, we used the whole blood cryopreservation method of Hininger et al. (6) . Since we observed more damage in these frozen samples compared with fresh whole blood, we optimised the protocol by changing the composition of the freezing medium. We used a medium composed of 70% RPMI 1640, 20% DMSO and 10% FCS instead of 80% RPMI 1640 and 20% DMSO (6) . Additionally, excess plasma was removed before adding freezing medium by shortly centrifuging the samples. If plasma was not removed before freezing, we observed an increase in DNA damage. We speculate that ice crystals formed in the aqueous plasma might cause mechanical damage. The applied protocol is similar to cryopreservation of isolated PBMC, where cells are also separated from plasma. Recently, Pu et al. (15) tested a similar freezing protocol; storing whole blood samples in RPMI 1640 media containing 10% FBS, 10% DMSO and 1 mM deferoxamine at either −20°C or −80°C. They reported significant increases in strand breaks and FPG-sensitive sites in samples stored at −20 °C for 14 and 28 days, but no significant changes were observed in whole blood samples and lymphocytes stored at −80 °C for up to 28 days. Interestingly, Al-Salmani et al. (16) described a method for cryopreservation of ±250-µl whole blood samples at −80°C for up to 1 month without adding freezing medium.
Finally, since exact cell concentrations are not needed to perform the comet assay, we did not count cells before freezing blood samples. As there can be some loss of cells during the washing step after thawing, it is recommended to resuspend the cell pellet in a PBS volume of circa 1/5 of the original blood volume.
Comparison between fresh whole blood, frozen whole blood and frozen isolated PBMC Most laboratories use isolated PBMC for comet analysis in biomonitoring studies (4) . Only few have reported the use of whole blood in human studies (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . In this study, both fresh and frozen whole blood samples and frozen isolated PBMC were available. Our results do not support the idea that isolation of PBMC might induce DNA damage. A limited number of publications compared the use of whole blood and isolated PBMC in the comet assay. The results are diverse. Some did not find differences between whole blood and PBMC for strand breaks (29) or for both strand breaks and FPGsensitive sites (5). Others observed relatively more strand breaks in polymorphonuclear leukocytes compared with PBMC (30,31), whereas one study reported less strand breaks and FPG-sensitive site in whole blood compared with isolated PBMC (32) . In our study, PBMC had in average slightly more FPG-sensitive sites than frozen whole blood (16.7 vs. 14.0% tail DNA, P < 0.05, Student's t-test). The latter is in line with observations in vitro, which show that isolated PBMC are more sensitive than whole blood to oxidative stress-inducing agents. This might be partly due to the isolation procedure (2) . Additionally, antioxidants in serum present in whole blood protect cells against oxidative damage. Furthermore, polymorphonuclear cells themselves produce a significant amount of free radicals as part of their physiological function. As a consequence, they need to be better protected against oxidative stress compared with PBMC (5). However, when our data were normalised for the Ro12-9786-exposed assay controls, no difference in the levels of FPG-sensitive sites detected in frozen PBMC or frozen whole blood was observed. It was recently discussed that assay controls are essential and should be included in each comet assay experiment (33) . A batch of positive assay controls can be prepared by exposing cells to an appropriate DNA-damaging agent. In the case of the FPG-comet assay, the photosensitisers Ro12-9786 or Ro 19-8022 are used most often, while KBr forms a good alternative (34, 35) . It is advisable to prepare a big enough batch and store small aliquots of the control cells at −80°C to be used during the whole project. Though, we had originally not planned to analyse the frozen whole blood samples a year later and so two different batches of Ro12-9786-exposed assay controls were prepared; one to analyse the fresh whole blood samples and frozen PBMC, and another one to analyse the frozen whole blood samples. This enabled us only to correct for assay controls within each series of experiments, but not for possible variations in the assays performed 1 year apart from each other. When the assay control shows a moderate deviation from the expected value, the data can be normalised using a correction factor (33) . Though, when the assay control shows a considerable deviation (e.g. 3 SDs of the mean) from the expected level of DNA damage, this can indicate that a technical problem and experiments should be repeated. While several laboratories make proper use of these assay controls and normalise their results for inter-assay variations, others even fail to report the levels detected for the assay controls.
Regardless the normalisation of the data for the Ro12-9786-exposed assay controls, the FPG-sensitive sites in frozen whole blood were not significantly correlated with FPG-sensitive sites in frozen PBMC ( Figure 4D ). Considering the difference in cell population of whole blood leukocytes compared with isolated PBMC, it is obvious that detected damage may vary to some extent. Whole blood leukocytes consist of >50% of granulocytes, with neutrophiles being the largest cell population. Lymphocytes and monocytes, which are the cells in the isolated PBMC fraction, only cover roughly 30 and 8% of the whole blood leukocytes (36) . Additionally, polymorphonuclear cells appear more granular in the comet assay image analysis. Because of this, the border between the head and the tail of the comet is less clear than with isolated PBMC. Hence, the tail might be slightly overestimated. Although it is possible to visually distinguish polymorphonuclear and mononuclear cells, this selection was not done by our automated scoring system. Aside from that, both polymorphonuclear leukocytes and PBMC differ in function and lifetime. Neutrophiles are short-living leukocytes (6-7 h in the bloodstream) involved in the inflammatory defense against bacteria, while lymphocytes are longer living (a few months) cells involved in specific immune responses (30) . These cell types, due to their different physiological roles and lifespan, reflect a different window and/ or a different type of exposure. This higher variability in cell types in whole blood samples compared with isolated PBMC was speculated to be the cause of a higher coefficient of variation (VC) in individual frozen whole blood slides compared with PBMC (VC 59 vs. 46% for FPG-treated slides).
Furthermore, our results indicate that there is no significant correlation between damage detected in fresh and frozen whole blood. The only significant correlation found was for strand breaks in frozen whole blood and in frozen PBMC ( Figure 4C , Pearson r = 0.54, P < 0.01). It is somewhat difficult to interpret these results. First, frozen whole blood was kept at −80°C for 1 year before analysis while frozen PBMC were processed after 4-6 weeks of preservation at −80°C. It could be speculated that freezing period influences DNA damage. However, we did not notice an overall increase in strand breaks or FPG-sensitive sites in frozen whole blood stored for 1 year compared with fresh samples. Another possibility is that the freezing or thawing process somehow affects the composition of the cell population and that whole blood samples become more 'PBMC-like'. It is generally known that isolated PBMC cells can be preserved at −80°C in freezing buffer for longer periods (12) (13) (14) . Based on our findings, this might not be the case for whole blood samples in which the viability of the polymorphonuclear cell fraction might be affected.
Conclusion
Our results show that cryopreservation of whole blood samples did not increase the detected level of strand breaks and FPG-sensitive sites. However, there was no significant correlation between fresh and frozen whole blood samples. The only significant correlation we observed was between strand breaks measured in frozen whole blood and frozen isolated PBMC, despite the different cryopreservation time of these samples. Though, since we were not able to properly correct for possible variations in the assays run 1 year apart from each other with assay controls, these correlations should be interpreted with care. Also we do not yet know the full extent to which cryopreservation might influence the blood cell population, care should be taken to ensure a similar cell type and storage for all samples in one study. Supplementary Figures 1-3 and Tables 1-3 are available at Mutagenesis Online.
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